Surgical Treatment of Pulmonary Aspergilloma

Document Type: Research Paper

Authors

1 Thoracic Surgeon, Lung disease Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

2 Thoracic Surgeon, department of general surgery, 5th of Azar Hospital, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran

3 Pulmonologist, Lung disease Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

4 Medical student, Student Research Committee, Faculty of medicine, Mashhad university of medical science, Mashhad, Iran

5 Medical student, Mashhad University of Medical Science, Mashhad, Iran

6 Medical student, Student Research Committee, Faculty of medicine, Mashhad University of Medical Science, Mashhad, Iran

7 Biologist, research expert, Lung disease Research Center, Emam Reza hospital, Mashhad university of medical science, Mashhad, Iran

Abstract

Introduction: Surgical approaches for the management of pulmonary aspergilloma have been accompanied with high levels of morbidity and mortality. However, these therapeutic options are still favored over other approaches for the treatment of Pulmonary Aspergilloma. In this study, we aimed to describe the characteristics of 30 patients with aspergilloma who referred to  Ghaem hospital between 2017-2018 and describe their results.
Materials and Methods: This retrospective study was conducted on 30 patients (i.e., 21 males and 9 females) with pulmonary aspergilloma who were treated via surgery. The patients were examined based on their age, gender, clinical symptoms prior to surgery, affected pulmonary lobe, surgical method, and postoperative complications.
Results: The mean age of the patients was 48.13(5.2) years. Hemoptysis (90%) was the most common symptom of pulmonary aspergilloma, followed by productive cough and drug-resistant pneumonia. The most common problematic lobes included left upper lobe and right upper lobe. Regarding the surgical method, 21 and 9 patients underwent lobectomy and segmentectomy, respectively. After the surgery, residual space, wound infection, ad bronchopleural fistula was observed in 5 (16.7%), 3 (10%), and 2 (6.7%) cases, respectively. Furthermore, only one patient passed away.
Conclusion: As the findings indicated, the methods of surgery (i.e., lobectomy and segmentectomy) showed effective treatment for patients.

Keywords


1.         Dogra V, Sinha AK, Saxena R, Talwar D. Aspergillus march: from ABPA to aspergilloma to subacute invasive aspergillosis. Allergy Asthma Clin Immunol. 2016; 12:64.

2.         Lee SH, Lee BJ, Jung DY, Kim JH, Sohn DS, Shin JW, et al. Clinical manifestations and treatment outcomes of pulmonary aspergilloma. Korean J Intern Med. 2004; 19:38-42.

3.         Mohapatra B, Sivakumar P, Bhattacharya S, Dutta S. Surgical treatment of pulmonary aspergillosis: a single center experience. Lung India. 2016; 33:9-13.

4.         Ruiz Júnior RL, Oliveira FH, Piotto BL, Muniz FA, Cataneo DC, Cataneo AJ. Surgical treatment of pulmonary aspergilloma. J Bras Pneumol. 2010; 36:779-83.

5.         Moodley L, Pillay J, Dheda K. Aspergilloma and the surgeon. J Thorac Dis. 2014; 6:202-9.

6.         Denning D. Chronic forms of pulmonary aspergillosis. Clin Microbiol Infect. 2001; 7:25-31.

7. Chamani J, Moosavi-Movahedi AA, Rajabi O, Gharanfoli M, Momen-Heravi M, Hakimelahi GH, Neamati-Baghsiah A, Varasteh AR. Cooperative α-helix formation of β-lactoglobulin induced by sodium n-alkyl sulfates. J Colloid Interf Sci. 2006; 293: 52-60.

8.         Stevens DA, Kan VL, Judson MA, Morrison VA, Dummer S, Denning DW, et al. Practice guidelines for diseases caused by Aspergillus. Clin Infect Dis. 2000; 30:696-709.

9.         Sagan D, Goździuk K. Surgery for pulmonary aspergilloma in immunocompetent patients: no benefit from adjuvant antifungal pharmacotherapy. Ann Thorac Surg. 2010; 89:1603-10.

10. Bakaeean B, Kabiri M, Iranfar H, Saberi MR, Chamani J. Binding effect of common ions to human serum albumin in the presence of norfloxacin: investigation with spectroscopic and zeta potential approaches. J Solution Chem. 2012; 41:1778-1801.

11.       Brik A, Salem AM, Abdel-Sadek M, Essa M, El Sharawy M, Deebes A, et al. Surgical outcome of pulmonary aspergilloma. Eur J Cardiothorac Surg. 2008; 34:882-5.

12. Naeeminejad S, Assaran Darban R, Beigoli S, Saberi MR, Chamani J. Studying the interaction between three synthesized heterocyclic sulfonamide compounds with hemoglobin by spectroscopy and molecular modeling techniques. J Biomol Struct Dyn. 2017; 35:3250-3267.

13.       Kim YT, Kang MC, Sung SW, Kim JH. Good long-term outcomes after surgical treatment of simple and complex pulmonary aspergilloma. Ann Thorac Surg. 2005; 79:294-8.

14.       Makino Y, Nishiyama O, Sano H, Iwanaga T, Higashimoto Y, Kume H, et al. Cavitary pulmonary cryptococcosis with an Aspergillus fungus ball. Intern Med. 2014; 53:2737-9.

15.       Chen QK, Jiang GN, Ding JA. Surgical treatment for pulmonary aspergilloma: a 35-year experience in the Chinese population. Interact Cardiovasc Thorac Surg. 2012; 15:77-80.

16. Danesh N, Navaee Sedighi Z, Beigoli S, Sharifi-Rad A, Saberi MR, Chamani J. Determining the binding site and binding affinity of estradiol to human serum albumin and holo-transferrin: fluorescence spectroscopic, isothermal titration calorimetry and molecular modeling approaches. J Biomol Struct Dyn. 2018; 36:1747-1763.

17.       Cesar JM, Resende JS, Amaral NF, Alves CM, Vilhena AF, Silva FL. Cavernostomy x resection for pulmonary aspergilloma: a 32-year history. J Cardiothorac Surg. 2011; 6:129.